The Stop TB Partnership invests significant effort to collaborate with the Global Fund, the largest international donor in the field of TB, and to support TB country programmes and partners to ensure the maximum impact and efficiency of investments to fight TB and to bring the voice of TB communities to the fore of the process.
Capacity building and technical assistance in priority areas related to TGF’s TB investments are delivered by the Stop TB Partnership’s Regional Advisors with engagement of CRG Program Officers of the Country and Community Support for Impact (CCS4i) team, the Global Drug Facility (GDF) and other Partnership’s teams, as well as by means of short-term technical assistance modalities engaging over 200 consultants from four Stop TB rosters of experts.
The Stop TB Partnership supports countries in the development of quality funding requests to the Global Fund, facilitation of participatory country dialogues with the engagement of civil society and communities affected by TB, and in the development of robust national TB strategic plans. Stop TB closely interacts with the Global Fund’s team of Disease Advisors on Tuberculosis, Regional Managers and Country Teams to support effective implementation through targeted technical assistance for strengthening TB diagnosis, treatment, and prevention, and developing proposals for portfolio optimization and reprogramming wherever required.
The Stop TB Partnership effectively contributes to the work of the Global Fund’s Board, Strategy Committee, Partnership Forums, Grant Approvals Committee, Technical Review Panel, and the Joint Working Group. As a key and active member of the ‘TB Situation Room’, along with the Global Fund, USAID and WHO, Stop TB works to improve access to funding and quality implementation of country grants and Strategic Initiatives, scale up innovations and best practices, and promote successful partnerships in the field of TB.
The COVID-19 pandemic has raised new challenges for TB. The Stop TB Partnership is actively engaged in supporting countries to mitigate the impact of COVID-19 on TB services through remote technical assistance and capacity building, impact modelling and guidance development, and facilitation of Global Fund support to countries through the COVID-19 Response Mechanism (C19RM).